Lexeo Therapeutics (LXEO) Treasury Shares (2022 - 2026)

Lexeo Therapeutics has reported Treasury Shares for 3 years, with the latest figure at $17000.0 in Q1 2026.

• Quarterly Treasury Shares changed 0.0% year-over-year to $17000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $17000.0 (changed 0.0% YoY) and the FY2025 annual result came in at $17000.0, changed 0.0% from the prior year.
• Treasury Shares steadied at $17000.0 in Q1 2026 per LXEO's latest filing, from $17000.0 in the prior quarter.
• Over five years, Treasury Shares peaked at $143.7 million in Q3 2022 and troughed at $3827.0 in Q4 2025.
• A 5-year average of $51.6 million and a median of $888222.5 in 2025 frame the typical range for Treasury Shares.
• The widest YoY moves for Treasury Shares: up 30.77% in 2025, down 0.0% in 2025.
• Over 3 years, Treasury Shares stood at $17000.0 in 2024, then changed by 0.0% to $17000.0 in 2025, then changed by 0.0% to $17000.0 in 2026.
• According to Business Quant data, Treasury Shares over the past three periods registered $17000.0, $17000.0, and $17000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.